Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Silvia Burlando"'
Autor:
María Lira, Francisco Rosa, Ignacio Aiello, Mileni Machado, Alejandra Palma, Leonardo Paz, María Güemes, Silvia Burlando, Pablo Azurmendi, Natalia Paladino, Mónica Costas, María Rubio
Publikováno v:
Oncology Reports. 49
Autor:
Maria Cecilia Lira, Francisco Damian Rosa, Ignacio Aiello, Mileni Soares Machado, Alejandra Graciela Palma, Leonardo Agustin Paz, Maria Cecilia Salazar Güemes, Silvia Burlando, Pablo Javier Azurmendi, Natalia Paladino, Monica Alejandra Costas, Maria Fernanda Rubio
Purpose NCoA3 is a transcriptional coactivator of NF-κB and other factors, present in undetectable levels into normal cells and amplified or overexpressed in several types of cancer, including breast tumors. We have previously demonstrated that NCoA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7599e76b0239d29771fc6056dedb1ec1
https://doi.org/10.21203/rs.3.rs-1730698/v1
https://doi.org/10.21203/rs.3.rs-1730698/v1
Publikováno v:
Baillière's Clinical Obstetrics and Gynaecology. 2:1037-1047
Autor:
Nidia Gomez Rueda, J Sardi, C. Sananes, Susana Vighi, A. Giaroli, Alberto Cachau, Guillermo di Paola, Silvia Burlando
Publikováno v:
Gynecologic Oncology. 32:360-364
Twenty-eight patients with squamous carcinoma of the cervix FIGO stage Ib were treated with three courses of neoadjuvant chemotherapy with a VBP modified scheme. Clinical response showed that the percentage of complete and moderate responses exceeds
Autor:
A. Giaroli, Susana Vighi, C. Sananes, Guillermo di Paola, Alberto Cachau, J Sardi, Nidia Gomez Rueda, Silvia Burlando
Publikováno v:
Gynecologic Oncology. 31:256-261
Results of a Phase II trial with neoadjuvant chemotherapy in carcinoma of the cervix uteri (VBP modified scheme) show that 85.7% of patients given this therapy were NED in Stage IIb versus 54% of a nonrandomized control group given conventional thera